Skip to main content
. 2014 Jan 30;5(1):1–3. doi: 10.1007/s13238-013-0003-2

Figure 1.

Figure 1

Differential immunogenicity of iPSC derivatives. The genetic and epigenetic defects induced by reprogramming are differentially presented during the iPSC differentiation leading to different consequences. The iPSC descendents without presentation of the defects during differentiation are not immunogenic. Tissues with pronounced defects are immunogenic, but may have distinct destiny